Our advice for clinicians on the coronavirus is here.
If you are a member of the public looking for information and advice about coronavirus (COVID-19), including information about the COVID-19 vaccine, go to the NHS website. You can also find guidance and support on the GOV.UK website.
You searched for: c1-esterase inhibitors
15573 results
F06. Specialised Immunology and Allergy Services
Scope This Clinical Reference Group (CRG) covers specialised treatment of certain immunological and allergic conditions. In relation to immunological conditions, this includes primary immunodeficiencies, autoimmune and autoinflammatory disease where there is associated immunodeficiency, complex autoimmune and vasculitic conditions and autoinflammatory syndromes. In relation to allergic conditions this includes severe, complex and/or rare sub-groups. Membership Dr. […]
Policies: Routinely commissioned
A commissioning policy is a document that defines access to a service for a particular group of patients. A NICE Technology Appraisal Guideline on the same topic will replace, or be incorporated into, a commissioning policy as appropriate. These are important documents that are developed to ensure consistency in access to treatments nationwide. Addition of […]
Clinical Commissioning Policy: Emicizumab as prophylaxis in people with congenital haemophilia A with factor VIII inhibitors (all ages)
This policy document outlines the arrangements for funding of treatment for people with congenital haemophilia A with factor VIII inhibitors.
Emicizumab as prophylaxis in people with severe congenital haemophilia A without factor VIII inhibitors (all ages)
NHS England will commission emicizumab as prophylaxis in people with severe congenital haemophilia A without factor VIII inhibitors in accordance with the criteria outlined in this policy.
Child Immunisation Q1 – Q4 2014/15
Child Immunisation Q1 – Q4 2014/15 Today NHS England published the latest experimental management information relating to Child Immunisation data for Q1 – Q4 2014/15. The data includes: DTaP/IPV/Hib – 12 month & 24 month MenC Primary – 12 month, 24 month & 5 year Hib Primary – 5 year PCV primary – 12 month […]
NHS Operational Planning and Contracting Guidance 2020/21 – Annex C: Finance
The purpose of these materials is to signpost stakeholders to key technical documents for financial planning, provide anticipated timescales for publication of materials and links associated for access.
Child Immunisation Q3 2014/15
Today NHS England published the latest experimental management information relating to Child Immunisation data for Q3 2014/15. The data includes: • DTaP/IPV/Hib – 12 month & 24 month • MenC Primary – 12 month, 24 month & 5 year • Hib Primary – 5 year • PCV primary – 12 month & 5 year • […]
New GPSoC contract to foster improved competition and innovation
NHS England and the Health and Social Care Information Centre (HSCIC) have announced the start of a new procurement process for an expanded framework of services and solutions for GP practices. The new GP System of Choice (GPSoC) contract will build on the success of the existing contract that has been in place since 2007. […]
Business continuity
Information last updated: 10 March 2016 NHS England Business Continuity Management Framework (service resilience) (2013): This document highlights the need for business continuity management in NHS organisations so that they can maintain continuity of key services in the face of disruption from identified local risks. This document replaces the ‘NHS Resilience and Business Continuity Management […]
Prescribed Services CQUIN Scheme: BI1 Improving Hepatitis C Virus treatment pathways through Operational Delivery Networks
This document contains information on the Prescribed Services Commissioning for Quality and Innovation (CQUIN) scheme 2017-19: BI1 Improving Hepatitis C Virus treatment pathways through Operational Delivery Networks.